Dew, I think you are right. I remember already in 2003 Infigen had to send home most of its staff due to a lack of revenues. In July 2004 Pharming bought all licenses from Infigen, which related to their outstanding collaboration (see below). In fact, I thought Infigen didn't exist anymore, but they must have been surviving in the hope that their IP might become interesting for third parties, so they could make a restart. It is sad to see that early innovators do not make it.
"Pharming has obtained worldwide, non-exclusive, royalty-free, non-terminable licenses from Infigen for patents on nuclear transfer and associated technologies. The new licensing agreement will replace earlier agreements between the companies. The financial terms of the agreement with Infigen were undisclosed and has been approved by the Board of Supervisory Directors. Infigen will also relinquish claims to any milestone payments for product development as defined under earlier agreements."